Dashboard
Manage Tickers

IMVT


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

oppenheimer-initiates-coverage-on-immunovant-with-outperform-rating-announces-price-target-of-50
Oppenheimer Initiates Coverage On Immunova...
03/28/2024 10:49:49

Oppenheimer analyst Leland Gershell initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Pr...

truist-securities-reiterates-buy-on-immunovant-maintains-48-price-target
Truist Securities Reiterates Buy on Immuno...
03/25/2024 16:11:34

Truist Securities analyst Robyn Karnauskas reiterates Immunovant (NASDAQ:IMVT) with a Buy and maintains $48 price target.

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

goldman-sachs-initiates-coverage-on-immunovant-with-buy-rating-announces-price-target-of-50
Goldman Sachs Initiates Coverage On Immuno...
03/13/2024 12:38:42

Goldman Sachs analyst Corinne Johnson initiates coverage on Immunovant (NASDAQ:IMVT) with a Buy rating and announces Price T...

immunovant-awarded-us-patent-for-imvt-1402
Immunovant Awarded U.S. Patent for IMVT-1402
03/12/2024 11:32:37

wolfe-research-initiates-coverage-on-immunovant-with-outperform-rating-announces-price-target-of-55
Wolfe Research Initiates Coverage On Immun...
02/15/2024 11:40:04

Wolfe Research analyst Andy Chen initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Price...

recap-immunovant-q3-earnings
Recap: Immunovant Q3 Earnings
02/12/2024 13:00:06

immunovant-q3-eps-036-up-from-049-yoy-cash-and-cash-equivalents-totaled-approximately-691m
Immunovant Q3 EPS $(0.36) Up From $(0.49) ...
02/12/2024 12:11:54

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.36) per share. This is a 26.53 percent increase over losses of $(0.49...

why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why CarMax Shares Are Trading Higher By Ar...
12/21/2023 18:01:44

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

b-of-a-securities-maintains-buy-on-immunovant-raises-price-target-to-51
B of A Securities Maintains Buy on Immunov...
12/21/2023 16:29:59

B of A Securities analyst Jason Gerberry maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $49 ...

autoimmune-disease-player-immunovants-investigational-drug-for-immune-system-disorder-shows-response-rates-of-over-50
Autoimmune Disease Player Immunovant's Inv...
12/21/2023 13:57:55

Immunovant Inc (NASDAQ: IMVT), on Thursday, released the results from the initial cohort of patients in an ongoing 24-week Phas...

amazoncom-to-rally-over-38-here-are-10-top-analyst-forecasts-for-thursday
Amazon.com To Rally Over 38%? Here Are 10 ...
12/21/2023 12:36:23

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

hc-wainwright--co-maintains-buy-on-immunovant-raises-price-target-to-51
HC Wainwright & Co. Maintains Buy on Immun...
12/21/2023 11:09:49

HC Wainwright & Co. analyst Douglas Tsao maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from ...

micron-posts-upbeat-sales-joins-calliditas-therapeutics-and-other-big-stocks-moving-higher-in-thursdays-pre-market-session
Micron Posts Upbeat Sales, Joins Callidita...
12/21/2023 10:27:25

U.S. stock futures were higher this morning, with the Dow Jones futures gaining more than 150 points on Thursday.

Core News & Articles
Immunovant Says Results From Initial Cohor...
12/20/2023 21:32:36

Batoclimab was generally well tolerated with no new safety signals observed in the initial data set. 

why-steelcase-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Steelcase Shares Are Trading Lower By ...
12/20/2023 18:16:08

Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.

fedex-posts-downbeat-earnings-joins-steelcase-argenx-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
FedEx Posts Downbeat Earnings, Joins Steel...
12/20/2023 10:33:14

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 30 points on Wednesday.

deutsche-bank-initiates-coverage-on-immunovant-with-buy-rating-announces-price-target-of-50
Deutsche Bank Initiates Coverage On Immuno...
12/12/2023 10:11:33

Deutsche Bank analyst Neena Bitritto-Garg initiates coverage on Immunovant (NASDAQ:IMVT) with a Buy rating and announces Pri...

analyst-ratings-for-immunovant
Analyst Ratings for Immunovant
12/01/2023 20:00:38

ubs-maintains-buy-on-immunovant-raises-price-target-to-56
UBS Maintains Buy on Immunovant, Raises Pr...
12/01/2023 18:30:26

UBS analyst Colin Bristow maintains Immunovant (NASDAQ:IMVT) with a Buy and raises the price target from $55 to $56.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION